AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ClearPoint Neuro, Inc. Director's Dealing 2025

Feb 25, 2025

32641_dirs_2025-02-25_53d790d8-ea77-4837-a5d6-8b351fb0118c.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ClearPoint Neuro, Inc. (CLPT)
CIK: 0001285550
Period of Report: 2025-02-22

Reporting Person: STIGALL L. JEREMY (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-02-22	Common Stock	F	908	$16.72	Disposed	47615	Direct

Footnotes

F1: Represents the amount of shares delivered to satisfy applicable tax withholding obligations in connection with the vesting of shares of restricted stock.